7 ms·
> The cancer vaccine: Moderna and pharma giant Merck are developing an mRNA-based cancer vaccine, mRNA-4157 (V940), for people who’ve had high-risk melanomas re
by satchlj 3y ago
> The cancer vaccine: Moderna and pharma giant Merck are developing an mRNA-based cancer vaccine, mRNA-4157 (V940), for people who’ve had high-risk melanomas removed.
- JumpCrisscross 3y ago> for people who’ve had high-risk melanomas removed This is still treatment. They aren’t administering the vaccine to healthy adults. The population is melanoma survivors with a high risk of recurrence.
- shadowgovt 3y agoIsn't this hair splitting on definitions? They are there for vaccinating against future instances of cancer after somebody is in remission from previous instances of cancer. It's not a generally-distributed vaccine, but there are all sorts of vaccines that aren't generally distributed and instead applied only to populations likely to encounter the illness protected against (such as the battery one is exposed to if one travels to particular parts of the world).
- KMag 3y agoThey're treating the traces of cancer that are very likely left behind after the melanoma removal, that are likely to result in recurrence.
- deleted 3y ago[deleted]